Início › Câncer de Mama › Virgínia › Richmond
Ensaios clínicos de Câncer de Mama em Richmond, VA
26 estudos para Câncer de Mama estão buscando participantes em locais em Richmond e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RecrutandoFase 3
- Bon Secours Virginia Health System, Midlothian · a 11 mi de distância
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- e mais 3
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
RecrutandoFase 2
- Virginia Cancer Institute, Richmond
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RecrutandoFase 3
- Bon Secours Cancer Institute at St. Francis ( Site 0048), Midlothian · a 11 mi de distância
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
RecrutandoFase 3
- VCU Health Adult Outpatient Pavillion ( Site 0070), Richmond
- Bon Secours St. Francis Medical Center-Oncology Research ( Site 0015), Midlothian · a 11 mi de distância
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RecrutandoFase 3
- Research Site, Midlothian · a 11 mi de distância
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RecrutandoFase 3
- Clinical Trial Site, Midlothian · a 11 mi de distância
Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab
Recrutando
- Adult Outpatient Pavilion, Richmond
- Cellular Immunotherapies and Transplant Department, Richmond
- VCU Health at Stony Point, Richmond
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RecrutandoFase 3
- Bon Secours Cancer Institute at St. Mary's, Richmond
- Bon Secours Cancer Institute at Memorial Regional, Mechanicsville · a 6 mi de distância
- Bon Secours St. Francis Medical Center, Midlothian · a 11 mi de distância
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RecrutandoFase 3
- Virginia Cancer Institute, Richmond
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
RecrutandoFase 3
- Research Site, Midlothian · a 11 mi de distância
The Vanguard Study: Testing a New Way to Screen for Cancer
RecrutandoVoluntários saudáveis bem-vindos
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecrutandoFase 3
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- e mais 4
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RecrutandoFase 2/3
- Bon Secours St. Francis Medical Center, Midlothian · a 11 mi de distância
E-Mindfulness Approaches for Living After Breast Cancer
RecrutandoFase 3
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Virginia Cancer Institute, Richmond
- e mais 4
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Recrutando
- Virgina Community University Massey Comprehensive Cancer Center, Richmond
Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation
RecrutandoFase 1
- Virginia Commonwealth University, Richmond
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
RecrutandoFase 3
- Virginia Commonwealth University, Richmond
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
RecrutandoFase 3
- Bon Secours St. Francis Medical Oncology Center, Midlothian · a 11 mi de distância
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RecrutandoFase 3
- Bon Secours Cancer Institute at Memorial Regional Medical Center, Mechanicsville · a 6 mi de distância
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RecrutandoFase 3
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- Bon Secours Memorial Regional Medical Center, Mechanicsville · a 6 mi de distância
- e mais 1
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecrutandoEstudo observacional
- VCU Massey Cancer Center at Stony Point, Richmond
- Virginia Commonwealth University/Massey Cancer Center, Richmond
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
RecrutandoEstudo observacional
- VCU Massey Comprehensive Cancer Center, Richmond
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RecrutandoEstudo observacional
- VCU Massey Comprehensive Cancer Center, Richmond
- Bon Secours Cancer Institute at St. Francis, Midlothian · a 11 mi de distância
ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
RecrutandoFase 2
- Virginia Commonwealth University, Richmond
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
RecrutandoVoluntários saudáveis bem-vindos
- Virginia Commonwealth University, Richmond
Ensaios de Câncer de Mama em outras cidades
- New York City, NY134 estudos
- Houston, TX126 estudos
- Boston, MA111 estudos
- Nashville, TN80 estudos
- Los Angeles, CA72 estudos
- Edison, NJ68 estudos
- St. Louis, MO64 estudos
- Durham, NC63 estudos
- Queens, NY63 estudos
- Chicago, IL58 estudos
- Philadelphia, PA56 estudos
- Dallas, TX55 estudos
Outros estudos em Richmond
- Câncer de Pulmão de Não Pequenas Células25 estudos
- Câncer de Próstata19 estudos
- Insuficiência Cardíaca16 estudos
- Câncer de Pulmão14 estudos
- Câncer Colorretal13 estudos
- Doença Cardiovascular13 estudos
- Doença Hepática Esteatótica12 estudos
- Leucemia Mieloide Aguda12 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço12 estudos
- Câncer Metastático12 estudos
- Melanoma11 estudos
- Obesidade11 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.